Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
1 - 18 of 18 results
Applied Filters
必威体育登录手机This application note introduces a method for target capture (long-read) sequencing using the Agilent SureSelect XT HS2 target enrichment system with some protocol modifications.
必威体育登录手机The Agilent Alissa Reporter platform is an intuitive and streamlined cloud-based NGS secondary analysis software-as-a-service solution.
必威体育登录手机Unlock the full potential of comprehensive genomic profiling (CGP) to advance precision oncology with the Agilent SureSelect Cancer CGP Assay, a targeted, pan-cancer panel based on next-generation sequencing.
Offers customized genomic profiling of cancer samples with custom NGS panels, which can incorporate new and emerging biomarkers.Enables assessment of CNVs, SNVs, indels, translocations, TMB, MSI.
User Guide for SureSelect Cancer CGP Assay and SureSelect Cancer Tumor-specific Assays.
Here we demonstrate robust, accurate, and reproducible enumeration of immune cell subsets from 36 whole blood samples using SureSelect XT HS2 RNA sequencing combined with CiberMed's iSort digital cytometry.
This application note describes the performance characteristics of the SureSelect CD Tissue panel for profiling both FF and FFPE tissue samples with a CiberMed digital cytometry software solution iSort.
Provides SureSelect XT HS2 index sequences in Excel format.Click the Sequence Resource link to download the .xlsx file to your local device (typically Downloads folder).
必威体育登录手机The Agilent Avida DNA cancer panels are optimized for sensitive and innovative target enrichment applications such as liquid biopsy and multiomics sequencing.
必威体育登录手机Agilent SureSelect CD TagTile panel for hybrid targeted RNA capture.
必威体育登录手机This flyer provides and overview of the family of Agilent SureSelect Community Designs designed by scientists in the Adam's Group at the Wellcome Sanger Institute.The aim of the research is to understand the genetics of cancer, using a combination...
SureSelect Targeted Panel Paired With iSort Enables Robust Enumeration of Immune Cell-type Abundances in Human Blood.
必威体育登录手机Agilent SureSelect CD CiberMed Tissue panel combined with the iSort software enables comprehensive cellular profiling of healthy and diseased tissue samples.
必威体育登录手机Agilent SureSelect CD CiberMed Heme and SureSelect CD CiberMed Heme + HiRes target enrichment panels combined with the iSortTM software offer a cellular profiling solution.
必威体育登录手机Developed by the Waterland team, the Agilent SureSelect CD Baylor Human CoRSIV panel enables researchers to optimally assay SIV in large population studies to discover associations with human diseases.
Accelerate the time from design to implementation of your Custom NGS Panels
Dr.David Gokhale and Dr.必威体育登录手机Luke Stuart from the North West Genomic Laboratory Hub, Saint Mary’s Hospital, Manchester, UK, have developed the Agilent SureSelect CD Carrier Screen panel.
必威体育登录手机David Gokhale, Ph.D., and other inherited disease experts at the North West Genomic Laboratory Hub, Saint Mary's Hospital, Manchester, UK, developed the Agilent SureSelect CD Clinical Focused Exome.